BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9451724)

  • 1. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Crespo JM; Menchon JM; Navarro MA
    Psychiatry Res; 1998 Jun; 82(3):161-70. PubMed ID: 9754440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.
    Rosel P; Menchon JM; Oros M; Vallejo J; Cortadellas T; Arranz B; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(1):89-96. PubMed ID: 9085196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
    Hrdina PD; Foy B; Hepner A; Summers RJ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.
    Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V
    J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.
    Cortés R; Soriano E; Pazos A; Probst A; Palacios JM
    Neuroscience; 1988 Nov; 27(2):473-96. PubMed ID: 2975361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
    Mellerup ET; Plenge P
    Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant binding: implications for the mode of action and the biology of depression.
    Hrdina PD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):457-62. PubMed ID: 6320297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin transporter from human brain: purification and partial characterization.
    Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
    Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat.
    Moret C; Briley M
    Psychiatry Res; 1991 Aug; 38(2):97-104. PubMed ID: 1836639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients.
    Rosel P; Arranz B; Vallejo J; Alvarez P; Menchon JM; Palencia T; Navarro MA
    J Affect Disord; 1999; 52(1-3):225-33. PubMed ID: 10357037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-binding sites in brain and platelets.
    Langer SZ; Galzin AM; Lee CR; Schoemaker H
    Ciba Found Symp; 1986; 123():3-29. PubMed ID: 3816412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.